BBCMF (Lir Life Sciences) Retained Earnings: $-2.14 Mil (As of Jan. 2026)


BBCMF Lir Life Sciences Corp BBCMF
15 GF Score
Price $0.05
View Full Analysis

What is Lir Life Sciences Retained Earnings?

Lir Life Sciences BBCMF 15 Retained Earnings is $-2.14 Mil as of Jan. 2026. GuruFocus rates BBCMF with a GF Score™ of 15/100.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Lir Life Sciences's retained earnings for the quarter that ended in Jan. 2026 was $-2.14 Mil.

Lir Life Sciences's quarterly retained earnings declined from Jul. 2025 ($-0.43 Mil) to Oct. 2025 ($-9.45 Mil) but then increased from Oct. 2025 ($-9.45 Mil) to Jan. 2026 ($-2.14 Mil).

Lir Life Sciences's annual retained earnings increased from . 20 ($0.00 Mil) to Apr. 2024 ($-0.02 Mil) but then declined from Apr. 2024 ($-0.02 Mil) to Apr. 2025 ($-0.32 Mil).


Lir Life Sciences  (OTCPK:BBCMF) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Lir Life Sciences Retained Earnings Historical Data

* Premium members only.

The historical data trend for Lir Life Sciences's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lir Life Sciences Retained Earnings Chart

Lir Life Sciences Annual Data
Trend Apr24 Apr25
Retained Earnings
-0.02 -0.32

Lir Life Sciences Quarterly Data
Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Retained Earnings Get a 7-Day Free Trial 0.00 -0.32 -0.43 -9.45 -2.14
BBCMF
15GF Score
Lir Life Sciences Corp BBCMF
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lir Life Sciences Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $-2.14 Mil mean?
Lir Life Sciences (BBCMF) has a Retained Earnings of $-2.14 Mil as of Jan. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Lir Life Sciences and its competitors.
Is Lir Life Sciences' Retained Earnings too high?
Lir Life Sciences' current Retained Earnings is $-2.14 Mil. Overall, Lir Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Lir Life Sciences' Retained Earnings compare to VRTX and REGN?
Lir Life Sciences' Retained Earnings of $-2.14 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Biotechnology company?
A good Retained Earnings depends on the Biotechnology industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Lir Life Sciences and its competitors. Lir Life Sciences's current Retained Earnings is $-2.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lir Life Sciences stock overvalued right now?
Lir Life Sciences (BBCMF) has a current Retained Earnings of $-2.14 Mil. The current Retained Earnings is $-2.14 Mil. Lir Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Lir Life Sciences (BBCMF), the current Retained Earnings is $-2.14 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lir Life Sciences Business Description

Other Exchanges N790:GermanySKNY:Canada
Address 505-1505 West 2nd Avenue, Vancouver, BC, CAN, V6J 1H2
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
15GF Score

Get the complete analysis for BBCMF

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.05
Price